IP Library Granted Patent US 11,129,973
Granted Patent B2
US 11,129,973 · App. 16/112,859 · Granted Sep 28, 2021

Drug delivery devices for deployment in genitourinary sites

Inventors: Paul DiCesare (Easton, CT); Jeffrey Radziunas (Wallingford, CT); Andrew Barnes (Naugatuck, CT); Eric Britschock (Willington, CT); David Sutton (Shelton, CT)
Assignee: TARIS BIOMEDICAL LLC
A61M31/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,129,973
App. No.
16/112,859
Granted
Sep 28, 2021
Kind
B2
Abstract

Implantable drug delivery devices are provided to have a deployment shape for implantation in the body and a retention shape for retention in the body. The device may have one or more elongated drug reservoirs containing a drug, and the drug reservoir may be formed from a deformable material. In one case, a first filament is attached to the first end of the drug reservoir and second filament is attached to the second end of the drug reservoir, wherein a fastener is positioned about the first and second filaments to permit shortening and prevent lengthening of the filaments with reference to the ends of the drug reservoir, as a means for transforming the device from the implantation shape to the retention shape.

Claims (8)

1. A drug delivery device comprising:

a shape-memory filament that is preprogrammed to achieve an expanded shape and is deformable into an elongated shape; and

a plurality of extended-release drug beads, each of which comprises a drug, spaced along the filament,

wherein the device is configured to be deployed in a genitourinary site within a human patient and then to release the drug to the site.

2. The device of claim 1 , wherein each of the drug beads is in the form of a bioresorbable matrix material in which the drug is dispersed.

3. The device of claim 1 , wherein the expanded shape is a coiled shape.

4. The device of claim 1 , wherein the device does not include a housing structure.

5. The device of claim 1 , which is configured to be deployed into the bladder of the patient through a catheter or cystoscope that extends through the urethra to the bladder.

Assignments (5)
MERGER Recorded Jun 1, 2026
From: TARIS BIOMEDICAL LLC
To: JANSSEN BIOTECH, INC.
Reel/Frame 074806/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2021
From: DICESARE, PAUL; RADZIUNAS, JEFFREY; BARNES, ANDREW; BRITSCHOCK, ERIC; SUTTON, DAVID
To: START LLC
Reel/Frame 057280/0020 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2021
From: START LLC
To: TARIS BIOMEDICAL INC.
Reel/Frame 057280/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2021
From: LIRIS BIOMEDICAL, INC.
To: TARIS BIOMEDICAL LLC
Reel/Frame 057282/0456 →
CHANGE OF NAME Recorded Aug 25, 2021
From: TARIS BIOMEDICAL, INC.
To: LIRIS BIOMEDICAL, INC.
Reel/Frame 057295/0955 →
Continuity (4)
Continuation 15056097 · Feb 29, 2016
Continuation 13813745
Provisional Application 61370902 · Aug 5, 2010
Related Publication 20190038883A1 · Feb 7, 2019